Prognostic significance of 18F-FDG PET/CT parameters in soft tissue sarcoma: a systematic review and meta-analysis

Prognostic significance of 18F-FDG PET/CT parameters in soft tissue sarcoma: a systematic review and meta-analysis

Abstract Background The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) parameters to predict prognosis for patients with soft tissue sarcoma (STS) remains controversial. Objectives This meta-analysis aimed to systematically evaluate the prognostic si...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shaoli Li, Rui Bai, Hui Wang, Qunan Sun, Guannan Wang, Sujing Jiang, Ying Dong
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Cancer Imaging
Subjects:	18F-Fluorodeoxyglucose positron emission tomography/computed tomography Prognosis Prediction Soft tissue sarcoma Meta-analysis
Online Access:	https://doi.org/10.1186/s40644-025-00912-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Central pontine myelinolysis and localized fluorodeoxyglucose uptake seen on 18 f-FDG PET/CT
by: Frederik Rønne, et al.
Published: (2017-01-01)

A unique case of increased 18f-FDG metabolic activity in the soft tissues of the bilateral upper thighs due to immunizations in a pediatric patient
by: Terrel Galloway, et al.
Published: (2017-01-01)

Research on the characteristics of 18F-FDG PET/CT in mantle cell lymphoma and the discrimination between cellular morphological variants
by: REN Yixuan, et al.
Published: (2024-12-01)

18F-FDG PET/CT-based deep learning models and a clinical-metabolic nomogram for predicting high-grade patterns in lung adenocarcinoma
by: Yue Guo, et al.
Published: (2025-04-01)

FDG-PET assessment of the locus coeruleus in Alzheimer’s disease
by: Kathy Y. Liu, et al.
Published: (2021-03-01)

Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients
by: Marc Bertaux, et al.
Published: (2025-05-01)

Use of 18F FDG PET and the short temporal response of Hodgkin's disease to RIT
by: Ewa Nowosinska, et al.
Published: (2018-07-01)

Role and Place of PET/CT in the Assessment of Skin Melanoma Prevalence
by: M. V. Sorokina, et al.
Published: (2022-07-01)

Heterogeneous marrow uptake on FDG PET/CT is not always a sign of lymphomatous involvement
by: Arun Reddy Gorla, et al.
Published: (2016-01-01)

FDG PET/CT AND PSMA PET/CT IN MUSCULOSKELETAL SOFT TISSUE SARCOMAS
by: Ellen Nogueira Lima, et al.
Published: (2025-05-01)

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CANCER PATIENTS: A WHOLE-BODY EXAMINATION PROCEDURE
by: O. V. Mukhortova, et al.
Published: (2014-09-01)

Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of breast carcinoma: Indications and pitfalls with illustrative case examples
by: Moheieldin Abouzied, et al.
Published: (2020-07-01)

Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy
by: Seyed Ali Mirshahvalad, et al.
Published: (2025-06-01)

Irritated seborrhoeic keratosis masquerading as malignancy on 18F-fluorodeoxyglucose positron emission tomography–computed tomography
by: Punit Sharma
Published: (2021-01-01)

Positive 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 20 Years after Talc Pleurodesis
by: Supriya A. Bhupathy, et al.
Published: (2022-12-01)

Knowledge and attitudes toward [18F] fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography among non-radiologist medical staff
by: Lei Zheng, et al.
Published: (2025-02-01)

Metabolic and multi-model intravoxel incoherent motion parameters based 18F-FDG PET/MRI for predicting subtypes of inoperable non-small cell lung cancer
by: Zhun Huang, et al.
Published: (2025-02-01)

Characterization of Pulmonary Sclerosing Pneumocytoma Assessed by 18F‐FDG PET/CT
by: Jie Xu, et al.
Published: (2025-07-01)

The Anatomical Biological Value on Pretreatment 18 F-fluorodeoxyglucose Positron Emission Tomography Computed Tomography Predicts Response and Survival in Locally Advanced Head and Neck Cancer
by: Hani Ashamalla, et al.
Published: (2014-04-01)

The Role of [<sup>18</sup>F]FDG PET Imaging for the Assessment of Vegetative State or Unresponsive Wakefulness Syndrome: A Systematic Review
by: Francesco Dondi, et al.
Published: (2025-05-01)

UNDIFFERENTIATED PLEOMORPHIC CARDIAC SARCOMA: THE ADVANTAGES OF PET/CT IN DETECTION OF LOCAL RECURRENCE AND DISTANT METASTASES (CASE REPORT)
by: D. V. Ryzhkova, et al.
Published: (2016-04-01)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

Dosimetric evaluation of extremities in 18F-FDG PET/CT procedure using Monte Carlo Geant4 code
by: Paula Rocha Pessanha, et al.
Published: (2019-10-01)

Incidental lung findings in a COVID-19 patient on 18F-FDG PET/CT done for preoperative evaluation of Marjolin's ulcer-first report from Chhattisgarh
by: Mudalsha Ravina, et al.
Published: (2021-07-01)

A case of dermatopathic lymphadenitis mimicking lymphoma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging
by: Koon Ng, et al.
Published: (2021-04-01)

18F-fluorodeoxyglucose positron emission tomography/computed tomography in childhood metastatic epithelioid hemangioendothelioma of the liver: Altering the management plan
by: Ashwin Singh Parihar, et al.
Published: (2019-04-01)

18F-fluorodeoxyglucose positron emission tomography/computed tomography in childhood metastatic epithelioid hemangioendothelioma of the liver: Altering the management plan
by: Ashwin Singh Parihar, et al.
Published: (2019-01-01)

Malignant perivascular epithelioid cell tumor of the ileum on 18F-fluorodeoxyglucose positron emission tomography/computed tomography with pathological correlation
by: Jeeban Das, et al.
Published: (2021-04-01)

Disseminated skeletal muscle and cardiac metastasis from squamous cell carcinoma of the lung detected with FDG and FLT PET/CT
by: Tarun Jain, et al.
Published: (2016-07-01)

The Role of [<sup>18</sup>F]FDG PET/CT Prior to and During Neoadjuvant Chemotherapy for Soft Tissue Sarcomas
by: Stijn J.C. van der Burg, et al.
Published: (2025-04-01)

A fully automated, expert-perceptive image quality assessment system for whole-body [18F]FDG PET/CT
by: Cong Zhang, et al.
Published: (2025-04-01)

Prognostic value of the pre-treatment SUVmax of 18F-FDG PET/CT combined with peripheral absolute lymphocyte in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
by: Xingmei Lu, et al.
Published: (2025-06-01)

18F-sodium fluoride PET-CT hybrid imaging of the lumbar facet joints: Tracer uptake and degree of correlation to CT-graded arthropathy
by: Marc Mabray, et al.
Published: (2016-04-01)

Unusual asymptomatic fluorodeoxyglucose avid pheochromocytoma in a case of myxoid liposarcoma of the extremity on 18-F fluorodeoxyglucose positron emission tomography-computed tomography
by: Divya Shivdasani, et al.
Published: (2017-07-01)

A Unique Case of Diffuse Metastatic Neuroendocrine Cancer with Subcutaneous Nodules on 18-F-Fluorodeoxyglucose Positron Emission Tomography/Computer Assisted Tomography
by: Mickaila Johnston, et al.
Published: (2015-04-01)

A case of invasive lobular carcinoma, highlighting the emerging role of 18F-Fluoroestradiol PET
by: Michael Wallace, MMS, MS, et al.
Published: (2025-10-01)

Presentation of unusual tracheal metastasis on Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography after 9 years in postnephrectomy patient of renal cell carcinoma: A case report and review of literature
by: Rahul Parghane, et al.
Published: (2017-07-01)

18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infected Polycystic Kidney Disease
by: Anna Paschali, et al.
Published: (2015-01-01)

The pearl of FDG PET/CT in preoperative assessment of patients with potentially operable non-small-cell lung cancer and its clinical impact
by: Boom Kung, et al.
Published: (2017-01-01)

Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?
by: Manoj Gupta, et al.
Published: (2017-04-01)